Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An optimised protocol for detection of SARS-CoV-2 in stool

T Li, View ORCID ProfileE Garcia-Gutierrez, J Scadden, J Davies, View ORCID ProfileC Hutchins, View ORCID ProfileA Aydin, View ORCID ProfileS Romano, View ORCID ProfileL Sayavedra, View ORCID ProfileJ O’Grady, A Narbad
doi: https://doi.org/10.1101/2021.01.11.20248606
T Li
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Garcia-Gutierrez
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E Garcia-Gutierrez
J Scadden
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Davies
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Hutchins
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C Hutchins
A Aydin
2Microbes in the Food Chain, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Aydin
S Romano
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Romano
  • For correspondence: Lizbeth.Sayavedra@quadram.ac.uk Stefano.Romano@quadram.ac.uk
L Sayavedra
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L Sayavedra
  • For correspondence: Lizbeth.Sayavedra@quadram.ac.uk Stefano.Romano@quadram.ac.uk
J O’Grady
2Microbes in the Food Chain, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J O’Grady
A Narbad
1Gut Health and Microbes, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Aim SARS-CoV-2 has been detected in stool samples of COVID-19 patients, with potential implications for faecal-oral transmission. Compared to swab samples, the complexity of the stool matrix poses a challenge in the detection of the virus that has not yet been solved. The aim of this study was to establish a sensitive and reliable method for detecting SARS-CoV-2 in stool samples.

Methods Stool samples from individuals free of SARS-CoV-2 were homogenised in saline buffer and spiked with a known titre of inactivated virus ranging from 50 to 750 viral particles per 100 mg stool. Debris was removed via centrifugation and supernatants were concentrated by ultrafiltration. RNA was then extracted from the concentrated material using a commercial kit and SARS-CoV-2 was detected via real-time reverse-transcription polymerase chain reaction (RT-qPCR) using the CDC primers and probes.

Results The RNA extraction procedure we used allowed the detection of SARS-CoV-2 via RT-qPCR in most of the stool samples tested. We could detect as few as 50 viral particles per 100 mg of stool. However, high variability was observed across samples at low viral titres. The primer set targeting the N1 region provided more reliable and precise results and for this primer set our method had a limit of detection of 1 viral particle per mg of stool.

Conclusions Here we describe a sensitive method for detecting SARS-CoV-2 in stool samples. This method can be used to establish the persistence of SARS-CoV-2 in stool and ensure the safety of clinical practices such as faecal microbiota transplant (FMT).

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by funding from the QIB, the Biotechnology and Biological Sciences Research Council (BBSRC) Impact Accelerator Account (BB/S506679/1), Institute Strategic Programme Gut Microbes and Health (BB/R012490/1) and its constituent projects BBS/E/F/000PR10355 and BBS/E/F/000PR10356, Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent projects BBS/E/F/000PR10348, BBS/E/F/000PR10349, BBS/E/F/000PR10351, and BBS/E/F/000PR10352.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Faecal samples were provided by different donors either via the NRP Biorepository from a study approved by the Ethical Review Committee of the University of East Anglia, Norwich (R204719) registered at http://www.clinicaltrials.gov/ (NCT03679533) or by a study approved by the QIB Human Research Governance committee (IFR01/2015) and registered at http://www.clinicaltrials.gov/ (NCT02653001).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are reported in the submitted manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An optimised protocol for detection of SARS-CoV-2 in stool
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An optimised protocol for detection of SARS-CoV-2 in stool
T Li, E Garcia-Gutierrez, J Scadden, J Davies, C Hutchins, A Aydin, S Romano, L Sayavedra, J O’Grady, A Narbad
medRxiv 2021.01.11.20248606; doi: https://doi.org/10.1101/2021.01.11.20248606
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An optimised protocol for detection of SARS-CoV-2 in stool
T Li, E Garcia-Gutierrez, J Scadden, J Davies, C Hutchins, A Aydin, S Romano, L Sayavedra, J O’Grady, A Narbad
medRxiv 2021.01.11.20248606; doi: https://doi.org/10.1101/2021.01.11.20248606

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)